KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	D-methylphenidate	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 84 💬
2	Methylphenidate	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[7] 6, 13, 34, 84, 113, 179, 206 💬
3	Methylphenidate (MPD)	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 6 💬
4	Methylphenidate (overencapsulated)	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 84 💬
5	Methylphenidate 10mg tablets	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 84 💬
6	METHYLPHENIDATE HYDROCHLORIDE	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[2] 6, 13 💬
7	Methylphenidate modified release	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 13 💬
8	Methylphenidate modified release 20 mg	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 13 💬
9	Methylphenidate modified release 30 mg	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 13 💬
10	Methylphenidate modified release 40 mg	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 13 💬
11	Methylphenidate Oral Solution	[1] Methylphenidate	[1] Methylphenidate 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬	[1] 206 💬
12	Methylphenidate, fluoxetin, risperidone	[3] Fluoxetine, Methylphenidate, Risperidone	[3] Fluoxetine , Risperidone , Methylphenidate 💬	[5] DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬	[14] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬	[2] 179, 206 💬